There are 3164 resources available
Q&A and discussion
Session: Improving the assessment of citizens perception of risk
Resources:
Webcast
1786O - BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study
Presenter: Ewa Kalinka
Session: Proffered Paper session: Non-metastatic NSCLC
Resources:
Abstract
Slides
Webcast
802MO - Real-world comparison of overall survival between BCMA - bispecific and CAR-T therapies in multiple myeloma
Presenter: Junmin Song
Session: Mini oral session 1: Haematological malignancies
Resources:
Abstract
Webcast
Which patients need surgery?
Presenter: Alexander van Akkooi
Session: Why neoadjuvant immunotherapy is the future for melanoma
Resources:
Slides
Webcast
EU HTA Regulation: State of play for cancer medicines
Presenter: Maya Matthews
Session: ESMO-MCBS: A practical tool with public health implications
Resources:
Slides
Webcast
Q&A and discussion
Session: Treating KRAS-mutated NSCLC
Resources:
Webcast
Q&A and discussion
Session: Metastatic colorectal cancer: Changing paradigms and the relevance for patient care
Resources:
Webcast
Q&A and discussion
Session: Antibody drug conjugates (ADCs): Are there new therapeutic approaches in gynaecological cancers?
Resources:
Webcast
Q&A
Session: Proffered paper session 1: GU tumours, non-prostate
Resources:
Webcast
Neoantigens derived from tryptophan depletion
Presenter: Reuven Agami
Session: Beyond coding neoantigens: What else is there for T cells to see?
Resources:
Slides
Webcast